Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Photorefractive Intrastromal Corneal Crosslinking (PiXL) for Correction of Hyperopia

NCT03805425 is registered in ClinicalTrials.gov with Gemini Eye Clinic as lead sponsor.

NCT NCT03805425
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03805425 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Photorefractive Intrastromal Corneal Crosslinking (PiXL) for Correction of Hyperopia
Lead sponsor
Gemini Eye Clinic
Phase
Not applicable
Overall status
Unknown status
Start date
December 31, 2016
Completion date
March 31, 2021
Enrollment
25 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

hyperopia